BMS Speeding Six More Programs Into Late-Stage R&D
Registrational Candidates Will Double Over 18 Months
With big losses of exclusivity later in this decade, Bristol is looking to boost the number of products in its portfolio by 2030 even beyond the $35bn-plus in new revenue it already expects to bring in.